Summary
CPhI's 6th Annual Pharma IPR conference will bring together professionals from leading Indian pharmaceutical companies and global law firms to discuss issues faced by the India pharma industry. Goodwin partner Bob Crawford will speak about strategies related to the settlement of Hatch-Waxman and biosimilars litigation, including recent FDA developments and reverse payments.
Speakers
- /en/people/c/crawford-jr-robert-milton
Robert M. Crawford Jr.
Partner